ADMA Biologics Inc —— 资产负债表 (NASDAQ:ADMA) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 207.67 M276.25 M348.46 M329.18 M488.68 M624.24 M 负债总额 119.42 M135.08 M196.49 M193.98 M139.66 M146.92 M 权益总额 88.25 M141.17 M151.97 M135.21 M349.02 M477.32 M 负债及股东权益总额 207.67 M276.25 M348.46 M329.18 M488.68 M624.24 M 总债务 92.97 M94.87 M142.83 M130.59 M72.34 M72.14 M 净债务 -44.19 M-48.76 M-87.73 M-45.98 M-97.25 M-11.65 M

新闻

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

Is ADMA Poised for Margin Growth and Supply Expansion in 2026?

Adma Biologics (ADMA) Laps the Stock Market: Here's Why

ADMA Biologics: The Short Report Is The Noise, Not The Signal (NASDAQ:ADMA)

Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026?

NVO Launches Wegovy Subscription Plan, Boosts Access, Stock Up

Biogen to Acquire Apellis for $5.6B to Strengthen Immunology Portfolio

Incyte Reports Strong 54-Week Data From Late-Stage Skin Disorder Study

ADMA Biologics: Differentiated Plasma Approach With Asymmetric Upside Potential (Upgrade)

Novartis Bolsters Immunology Pipeline With Excellergy Deal

Novo Nordisk's Awiqli Gets FDA Approval for Type II Diabetes

KOD Stock Soars on Promising Phase III Data for Eye Disease Candidate